Related Experiment Video
Updated: Aug 15, 2025
07:00
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
8.2K
Clinical Signs in Neuro-Ophthalmology: Eye Signs in Myasthenia Gravis
1Moorfields Eye Hospital NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, King's College London, University College London, London, United Kingdom.
Annals of Indian Academy of Neurology
|January 2, 2023
Summary
Myasthenia gravis (MG) causes muscle weakness that worsens with activity, often affecting eye muscles leading to ptosis and diplopia. This guide details recognizing and examining these specific ocular manifestations in MG patients.
Area of Science:
- Ophthalmology
- Neurology
- Clinical Medicine
Background:
- Myasthenia gravis (MG) is characterized by fluctuating muscle weakness and fatigability.
- Ocular symptoms, including ptosis and diplopia, are primary manifestations in most MG patients.
Purpose of the Study:
- To outline the characteristic eye signs associated with myasthenia gravis.
- To provide practical guidance on examination techniques for diagnosing MG-related ocular symptoms.
- To highlight common pitfalls during the clinical assessment of eye signs in MG.
Main Methods:
- Review of clinical signs and examination protocols for myasthenia gravis.
- Emphasis on specific tests to elicit fatigability in ocular muscles.
- Discussion of diagnostic challenges and avoidance of misinterpretations.
Main Results:
- Detailed description of ptosis and diplopia as key indicators of MG.
- Identification of specific maneuvers to assess muscle fatigability in the eyes.
- Enumeration of potential diagnostic errors and how to prevent them.
Conclusions:
- Ocular signs are critical for diagnosing myasthenia gravis.
- Standardized examination techniques improve the detection of MG-related eye conditions.
- Awareness of examination pitfalls enhances diagnostic accuracy for ptosis and diplopia in MG.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
01:28Disorders of the Skeletal Muscle
1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
01:15Myasthenia Gravis: Diagnostic Tests
1.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
01:26Chemical Synapses
9.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.0K
01:17Accessory Structures of the Eye
1.7K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.7K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
745
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
745